3Anon.Videx C reduce GI side-effects[J].J Antimicrob Chemother,2000,45(4):417.
4Drake SM.NNRTIs-a new class of drugs for HIV[J].J Antimicrob Chemother,2000,45(4):417.
5Aduma P,Connelly MC,Srinivas RV,et al.Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates[J].Mol Pharmacal,1995,47(4):816～822.
6Sorbera LA,Castaner R Castaner J.Valganciclovir Hydrochloride anti-cytomegalovirus drug[J].Drugs Fut.2000,25(5):477.
7Neri S,Pistone G,Saraceno B,et al,L-Carnitine decreases severity of patients with hepatitis C[J].Neuropsy-chobiology,2003,47(2):94～97.
8Younossi ZM,Mullen KD,Hodnick S,et al Triple combination of interferon alpha-2b,ribavirin,and amantadine for treatment of chronic hepatitis C[J]J Clin Gastroenterol,2003,36(5):427～430.
9Anon.Drug future.2002,27(7),702.
10Pillay D,Mutimer D,Singhal S,et al.Management of herpes virus infection following transplantation.A report form the British Society for antimicrobial chemotherapy working party on antiviral therapy[J],J Antimicrob Chemother.2000,45(6):729.
